FDA Approves GLIPIZIDE AND METFORMIN HCL — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has secured approval for its generic version of GLIPIZIDE AND METFORMIN HCL, marking a development in the antidiabetic market that may pressure branded competition. The 2010 approval grants Aveston access to a high-volume segment of the combined therapy space, potentially positioning the company to influence pricing dynamics for diabetes management.